Related content

The Clinical Utility and Limitations of Serum Carbohydrate Antigen (CA19-9) as a Diagnostic Tool for Pancreatic Cancer and Cholangiocarcinoma

By Singh Sundeep  

Digestive Diseases and Sciences, Vol. 56, Iss. 8, 2011-08 ,pp. : 2491-2496

Springer Publishing Company

Access to resources Recommend Favorite

CA 19-9 to Rule Out Pancreatic or Biliary Cancer Among Patients with Cholestasis: An Unsuitable Test?

By Madonia Salvatore   Aragona Emma   Maisano Simonetta   Montalbano Luigi   Olivo Mirko   Rossi Francesca   Restivo Gaetano   Cottone Mario  

Digestive Diseases and Sciences, Vol. 52, Iss. 4, 2007-04 ,pp. : 1125-1127

Springer Publishing Company

Access to resources Recommend Favorite

The Value of Serum CA 19-9 in Predicting Cholangiocarcinomas in Patients with Primary Sclerosing Cholangitis

By Levy Cynthia   Lymp James   Angulo Paul   Gores Gregory   Larusso Nicholas   Lindor Keith  

Digestive Diseases and Sciences, Vol. 50, Iss. 9, 2005-09 ,pp. : 1734-1740

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of risk of malignancy index (RMI), CA125, CA 19-9, ultrasound score, and menopausal status in borderline ovarian tumor

By Alanbay İbrahim   Akturk Erhan   Coksuer Hakan   Ercan Mutlu   Karaşahin Emre   Dede Murat   Yenen Mufit Cemal   Ozan Hakan   Baser İskender  

Gynecological Endocrinology, Vol. 28, Iss. 6, 2012-06 ,pp. : 478-482

Informa Healthcare

Access to resources Recommend Favorite

The Combined Elevation of Tumor Markers CA 19-9 and CA 125 in Liver Disease Patients Is Highly Specific for Severe Liver Fibrosis

By Schöniger-Hekele Maximilian   Müller Christian  

Digestive Diseases and Sciences, Vol. 51, Iss. 2, 2006-02 ,pp. : 338-345

Springer Publishing Company

Access to resources Recommend Favorite